Update on the role of antipsychotics in the treatment of Tourette syndrome
Authors:
- Daniel HuysDHDaniel Huys
- Katja HardenackeKHKatja Hardenacke
- Pia PoppePPPia Poppe
- Burak BaskinBBBurak Baskin
- Christina BartschCBChristina Bartsch
- Jens KuhnJKJens Kuhn
Open Access
- 1 March 2012
- journal article
- review article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. 8, 95-104
Abstract
Tourette syndrome (TS) is a neuropsychiatric disorder with typical onset in childhood and characterized by chronic occurrence of motor and vocal tics. The disorder can lead to serious impairments of both quality of life and psychosocial functioning, particularly for those individuals displaying complex tics. In such patients, drug treatment is recommended. The pathophysiology of TS is thought to involve a dysfunction of basal ganglia-related circuits and hyperactive dopaminergic innervations. Congruently, dopamine receptor antagonism of neuroleptics appears to be the most efficacious approach for pharmacological intervention. To assess the efficacy of the different neuroleptics available, a systematic, keyword-related search in PubMed (National Library of Medicine, Washington, DC) was undertaken. Much information on the use of antipsychotics in the treatment of TS is based on older data. Our objective was to give an update and therefore we focused on papers published in the last decade (between 2001 and 2011). Accordingly, the present review aims to summarize the current and evidence-based knowledge on the risk-benefit ratio of both first and second generation neuroleptics in TS.Keywords
This publication has 120 references indexed in Scilit:
- Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability StudyJournal of Child and Adolescent Psychopharmacology, 2009
- Short-term Sulpiride Treatment of Children and Adolescents With Tourette Syndrome or Chronic Tic DisorderJournal of the Formosan Medical Association, 2009
- Effectiveness and Tolerability of Open Label Olanzapine in Children and Adolescents with Tourette SyndromeJournal of Child and Adolescent Psychopharmacology, 2008
- Clinical Effectiveness of Quetiapine in Children and Adolescents with Tourette???s SyndromeClinical Drug Investigation, 2007
- Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adultsNuclear Medicine Communications, 2006
- Effectiveness and Safety of Risperidone for Children and Adolescents with Chronic Tic or Tourette Disorders in KoreaJournal of Child and Adolescent Psychopharmacology, 2005
- Aripiprazol e síndrome de TouretteBrazilian Journal of Psychiatry, 2004
- Quetiapine Treatment of Children and Adolescents with Tourette's DisorderJournal of Child and Adolescent Psychopharmacology, 2003
- An Open-Label Study of the Treatment Efficacy of Olanzapine for Tourette's DisorderThe Journal of Clinical Psychiatry, 2001
- Management of Gilles de la Tourette Syndrome Using SulpirideClinical Neuropharmacology, 1990